Detalles de la búsqueda
1.
The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
Neuropharmacology
; 54(2): 331-43, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18037451
2.
Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain.
Psychopharmacology (Berl)
; 182(4): 551-61, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16133135
3.
CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate.
Front Pharmacol
; 3: 11, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22347859
4.
Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
Behav Brain Res
; 198(2): 481-5, 2009 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-19162078
Resultados
1 -
4
de 4
1
Próxima >
>>